Beatrice M. Seddon

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Optimal clinical management of tenosynovial giant cell tumours: a UK perspective.

Optimal clinical management of tenosynovial giant cell tumours: a UK perspective.

Journal: Bone & joint open

Published: April 02, 2026

Local Control With Moderately Hypofractionated Definitive Radiotherapy Delivered With a Simultaneous Integrated Boost Technique to Non-extremity Soft Tissue and Bone Sarcomas.

Local Control With Moderately Hypofractionated Definitive Radiotherapy Delivered With a Simultaneous Integrated Boost Technique to Non-extremity Soft Tissue and Bone Sarcomas.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 02, 2025

Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocol.

Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocol.

Journal: BMJ open

Published: August 09, 2024

UK guidelines for the management of bone sarcomas.

UK guidelines for the management of bone sarcomas.

Journal: British journal of cancer

Published: February 11, 2024

UK guidelines for the management of soft tissue sarcomas.

UK guidelines for the management of soft tissue sarcomas.

Journal: British journal of cancer

Published: January 08, 2024

The IMRiS Trial: A Phase 2 Study of Intensity Modulated Radiation Therapy in Extremity Soft Tissue Sarcoma.

The IMRiS Trial: A Phase 2 Study of Intensity Modulated Radiation Therapy in Extremity Soft Tissue Sarcoma.

Journal: International journal of radiation oncology, biology, physics

Published: December 20, 2023

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.

Journal: British journal of cancer

Published: January 26, 2023

Heritable defects in telomere and mitotic function selectively predispose to sarcomas.

Heritable defects in telomere and mitotic function selectively predispose to sarcomas.

Journal: Science (New York, N.Y.)

Published: January 19, 2023

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.

Journal: Cancer treatment reviews

Published: November 22, 2022

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.

Journal: British journal of cancer

Published: February 25, 2022

Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma.

Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 16, 2022

New Guidance From The Royal College of Radiologists on Incidental Irradiation of the Spleen: What Does it Say and Why Does it Matter?

New Guidance From The Royal College of Radiologists on Incidental Irradiation of the Spleen: What Does it Say and Why Does it Matter?

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 28, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026